Found 88 matching trials
Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients PHASE2 The aim of this study is to evaluate the synergistic anti-tumor effect of C...
Show More Learn More & Join Trial
Study of Folfox4 Chemotherapy Regimen to Prevent Early Postoperative Recurrence for HCC-PVTT Patients NA This study is to investigate the efficacy and safety of Folfox4 chemotherap...
Show More Location
Multiple Locations
Learn More & Join Trial
Side Effects to FOLFOXIRI + Tocotrienol/Placebo as First Line Treatment of Metastatic Colorectal Cancer PHASE2 Treatment with FOLFOXIRI (5-fluorouracil, oxaliplatin, irinotecan) can be e...
Show More Location
Department of Oncology, Vejle Hospital
Learn More & Join Trial
A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma PHASE2 This clinical trial will compare the efficacy and safety of the combination...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 ) PHASE3 The purpose of this study is to evaluate the efficacy of an investigational...
Show More Location
The University of Arizona Cancer Center-North Campus
Learn More & Join Trial
Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer PHASE2 This randomized phase II trial studies combination chemotherapy when given ...
Show More Location
University of California at Davis Cancer Center
Learn More & Join Trial
Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy PHASE2 The purpose of this study is to estimate the usefulness and safety of HD661...
Show More Location
Jiangsu Province Hospital of Integrated Chinese and Western Medicine
Learn More & Join Trial
Lidocaine for Oxaliplatin-induced Neuropathy PHASE1 Oxaliplatin-induced neuropathy is a major dose-limiting side effect in pati...
Show More Location
Washington University School of Medicine/Barnes Jewish Hospital
Learn More & Join Trial
Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC): PHASE3 This was a randomized, double-blind, placebo-controlled, global, multicente...
Show More Location
AZ Oncology Associates - HOPE
Learn More & Join Trial
Tocotrienol and Bevacizumab in Metastatic Colorectal Cancer PHASE2 This double blind, randomized phase II trial will investigate whether the a...
Show More Status
Active Not Recruiting
Location
Department of Oncology, Vejle Hospital
Learn More & Join Trial